MDxHealth
MDXH
MDxHealth (MDXH) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $2.00 from $4.00 | Aug 21, 2026 |
| Lake Street | Maintained | Buy | $3.00 from $5.00 | Aug 14, 2026 |
| BTIG | Maintained | Buy | $4.00 from $7.00 | May 14, 2026 |
| TD Cowen | Maintained | Buy | $1.50 from $7.00 | May 14, 2026 |
| Lake Street | Maintained | Buy | $5.00 from $9.00 | May 14, 2026 |
| BTIG | Maintained | Buy | $7.00 | Dec 23, 2025 |
| BTIG | Maintained | Buy | $7.00 from $6.00 | Nov 13, 2025 |
| Lake Street | Maintained | Buy | $9.00 from $7.00 | Nov 13, 2025 |
| TD Cowen | Maintained | Buy | $7.00 from $5.00 | Nov 13, 2025 |
| Piper Sandler | Maintained | Overweight | $6.00 from $8.00 | Nov 7, 2024 |
| Lake Street | Initiated Coverage | Buy | $7.00 | Oct 31, 2024 |
| BTIG | Maintained | Buy | $8.00 from $7.00 | Mar 7, 2024 |
| Piper Sandler | Maintained | Overweight | $7.00 from $6.00 | Mar 7, 2024 |
| Piper Sandler | Maintained | Overweight | $6.00 from $10.00 | Nov 9, 2023 |
| BTIG | Maintained | Buy | $7.00 from $8.00 | May 16, 2023 |
Frequently asked questions
What is the latest analyst rating on MDXH?
On Aug 21, 2026, BTIG maintained MDxHealth at Buy with a price target of $2.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.